TLDN yields 666666.67% · PFE yields 6.13%● Live data
📍 TLDN pulled ahead of the other in Year 1
Combined, TLDN + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TLDN + PFE for your $10,000?
Telidyne Inc. primarily designs, produces, and sells transmission towers and related products used in high voltage electric power transmission and wireless communications. The company's electric transmission and wireless communications product lines include angle steel towers, steel pipe towers, and transmission cable towers constructed primarily of steel, aluminum, or other alloy materials. Its wireless communication towers comprise single-tube towers, 4-strut towers, and roof top towers for the 2G, 3G, and microwave market. The company's electric transmission towers support 35kv, 110kv, 220kv, and 500kv transmission lines. It also provides telecommunication equipment, scrap, and technical consulting services. Telidyne Inc. sells its tower products to prime contractors on large transmission projects for electric utility companies or telecommunications service providers developing and constructing projects for end customers. The company was formerly known as TEC Technology, Inc. and changed its name to Telidyne Inc. in April 2018. The company was founded in 2006 and is based in New York, New York.
Full TLDN Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.